- Report
- November 2021
Europe
From €22443EUR$24,500USD£19,075GBP
- Report
- November 2021
Asia Pacific
From €13283EUR$14,500USD£11,289GBP
- Report
- November 2021
Global
From €31604EUR$34,500USD£26,860GBP
- Report
- September 2024
- 205 Pages
Middle East, Africa, Europe Middle East, Africa, Europe
From €1552EUR$1,694USD£1,319GBP
€2217EUR$2,420USD£1,884GBP
- Report
- July 2024
- 228 Pages
Global
From €1702EUR$1,859USD£1,447GBP
€2432EUR$2,655USD£2,067GBP
- Report
- January 2024
- 283 Pages
Global
From €2289EUR$2,499USD£1,946GBP
€3270EUR$3,570USD£2,779GBP
Thrombin is a hematological drug used to treat bleeding disorders. It is a naturally occurring enzyme in the body that helps to form blood clots. Thrombin is used to treat a variety of conditions, including hemophilia, deep vein thrombosis, and pulmonary embolism. It is also used to help control bleeding during surgery. Thrombin is available in both injectable and topical forms. The injectable form is used to treat more serious conditions, while the topical form is used to treat minor cuts and scrapes.
The thrombin market is highly competitive, with a number of companies offering products. Some of the major players in the market include Pfizer, Novo Nordisk, Bayer, and Sanofi. Other companies in the market include CSL Behring, Grifols, and Kedrion Biopharma. Show Less Read more
